{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:54:30Z","timestamp":1778320470757,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.urolonc.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T11:35:19Z","timestamp":1720524919000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical considerations for sexual and gender minorities with prostate cancer"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4606-5574","authenticated-orcid":false,"given":"Daniel R.","family":"Dickstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Channa","family":"Amarasekera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.urolonc.2024.06.008_bib0001","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41585-023-00778-3","article-title":"Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer","volume":"20","author":"Dickstein","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad075","article-title":"Do ask, do tell: improving health outcomes for sexual and gender minorities with cancer","volume":"7","author":"Dickstein","year":"2023","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.urolonc.2024.06.008_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0004","doi-asserted-by":"crossref","first-page":"k3519","DOI":"10.1136\/bmj.k3519","article-title":"Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis","volume":"362","author":"Ilic","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0005","unstructured":"Preston MA. Screening for Prostate Cancer. In: Joann G, Elmore MPOL, ed. UpToDate. 2023."},{"issue":"12","key":"10.1016\/j.urolonc.2024.06.008_bib0006","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.clon.2021.07.010","article-title":"Developing UK guidance on how long men should abstain from receiving anal sex before, during and after interventions for prostate cancer","volume":"33","author":"Ralph","year":"2021","journal-title":"Clin Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2024.06.008_bib0007","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.urolonc.2024.06.008_bib0008","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.urolonc.2024.06.008_bib0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.812117","article-title":"Health disparities of sexual minority patients following prostate cancer treatment: results from the restore-2 study","volume":"12","author":"Rosser","year":"2022","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.urolonc.2024.06.008_bib0011","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41585-022-00600-6","article-title":"Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer","volume":"19","author":"Dickstein","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41585-024-00892-w","article-title":"Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself","author":"Dickstein","year":"2024","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0013","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-024-00932-1","article-title":"Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus","author":"Dickstein","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.06.008_bib0014","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijrobp.2022.12.001","article-title":"Inclusion of Sexual Orientation and Gender Identity in Clinical Trials Is Necessary for Health Equity","volume":"116","author":"Chen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.urolonc.2024.06.008_bib0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10508-016-0738-y","article-title":"Sexual positioning among men who have sex with men: a narrative review","volume":"46","author":"Dangerfield","year":"2017","journal-title":"Arch Sex Behav"},{"issue":"5","key":"10.1016\/j.urolonc.2024.06.008_bib0016","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10508-018-1360-y","article-title":"The Sexual functioning of gay and bisexual men following prostate cancer treatment: results from the restore study","volume":"49","author":"Rosser","year":"2020","journal-title":"Arch Sex Behav"},{"issue":"4","key":"10.1016\/j.urolonc.2024.06.008_bib0017","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10508-018-1240-5","article-title":"Bottom, and versatile anal sex roles in same-sex male relationships: implications for relationship and sexual satisfaction","volume":"48","author":"Moskowitz","year":"2019","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102659","article-title":"Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia","volume":"76","author":"Vaccher","year":"2020","journal-title":"Intl J Drug Policy"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0019","doi-asserted-by":"crossref","unstructured":"Schwartz BG, Kloner RA. Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation. 2010;122(1):88-95. doi:10.1161\/CIRCULATIONAHA.110.944603","DOI":"10.1161\/CIRCULATIONAHA.110.944603"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.832508","article-title":"Prevalence and risk factors for sexually transmitted infections in gay and bisexual prostate cancer survivors: results from the restore-2 study","volume":"12","author":"Wheldon","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0021","doi-asserted-by":"crossref","unstructured":"Molina JM, Charreau I, Chidiac C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18(3):308-317. doi:10.1016\/s1473-3099(17)30725-9","DOI":"10.1016\/S1473-3099(17)30725-9"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.urology.2023.05.019","article-title":"Urologists and lesbian, gay, bisexual, transgender, or queer patients: a survey-based study of the practice patterns, attitudes, and knowledge base of urologists toward their lesbian, gay, bisexual, transgender, or queer patients","volume":"179","author":"Xu","year":"2023","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2024.06.008_bib0023","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.brachy.2016.03.012","article-title":"Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy","volume":"15","author":"Nasser","year":"2016","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.urolonc.2024.06.008_bib0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00926230590477989","article-title":"Anodyspareunia in men who have sex with men: prevalence, predictors, consequences and the development of DSM diagnostic criteria","volume":"31","author":"Damon","year":"2005","journal-title":"J Sex Marital Ther"},{"issue":"4","key":"10.1016\/j.urolonc.2024.06.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174981","article-title":"Sexual function and satisfaction among heterosexual and sexual minority U.S. adults: a cross-sectional survey","volume":"12","author":"Flynn","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.urolonc.2024.06.008_bib0026","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jsxm.2021.12.012","article-title":"Creation and psychometric validation of the sexual minorities and prostate cancer scale (SMACS) in sexual minority patients-the restore-2 study","volume":"19","author":"Polter","year":"2022","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.urolonc.2024.06.008_bib0027","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijrobp.2023.05.028","article-title":"Gender-affirming surgery and cancer: considerations for radiation oncologists for pelvic radiation in transfeminine patients","volume":"117","author":"Smart","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/638919","article-title":"An overview of neovaginal reconstruction options in male to female transsexuals","volume":"2014","author":"Bizic","year":"2014","journal-title":"Sci World J"},{"issue":"1","key":"10.1016\/j.urolonc.2024.06.008_bib0029","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eururo.2022.09.007","article-title":"Prostate-specific antigen screening in transgender patients","volume":"83","author":"Nik-Ahd","year":"2023","journal-title":"Eur Urol"},{"issue":"21","key":"10.1016\/j.urolonc.2024.06.008_bib0030","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.2023.6028","article-title":"Prostate cancer in transgender women in the veterans affairs health system, 2000-2022","volume":"329","author":"Nik-Ahd","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.urolonc.2024.06.008_bib0031","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1215\/00703370-9942002","article-title":"Differences in all-cause mortality among transgender and non-transgender people enrolled in private insurance","volume":"59","author":"Hughes","year":"2022","journal-title":"Demography"},{"issue":"2","key":"10.1016\/j.urolonc.2024.06.008_bib0032","first-page":"63","article-title":"Embryologic and hormonal contributors to prostate cancer in transgender women","volume":"10","author":"Gaglani","year":"2022","journal-title":"Am J Clin Exp Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2024.06.008_bib0033","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jcem.84.12.6206","article-title":"Long-term consequences of castration in men: lessons from the skoptzy and the eunuchs of the chinese and ottoman courts","volume":"84","author":"Wilson","year":"1999","journal-title":"Journal of Clin Endocrinol Metabol"},{"key":"10.1016\/j.urolonc.2024.06.008_bib0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2021.07.027","article-title":"Prostate cancer screening for gay men in the United States","volume":"163","author":"Wilcox Vanden Berg","year":"2022","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2024.06.008_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41585-023-00780-9","article-title":"Prostate cancer is not just a man's concern - the use of PSA screening in transgender women","volume":"20","author":"Nik-Ahd","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2024.06.008_bib0036","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s11912-023-01470-w","article-title":"Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges","volume":"25","author":"Manfredi","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.urolonc.2024.06.008_bib0037","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bju.15521","article-title":"Prostate cancer in transgender women: what does a urologist need to know?","volume":"129","author":"Bertoncelli Tanaka","year":"2022","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2024.06.008_bib0038","first-page":"35","article-title":"Gynaecological aspects of the treatment and follow-up of transsexual men and women","volume":"2","author":"Weyers","year":"2010","journal-title":"Facts Views Vis Obgyn"},{"issue":"1","key":"10.1016\/j.urolonc.2024.06.008_bib0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00259-019-04529-8","article-title":"Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients","volume":"47","author":"Vaz","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.urolonc.2024.06.008_bib0040","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00259-017-3700-x","article-title":"PET and PET\/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies","volume":"44","author":"Giovacchini","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T10:49:04Z","timestamp":1725360544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924005076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1078143924005076"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.06.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical considerations for sexual and gender minorities with prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}